Bausch Health, which owns 88% of Bausch + Lomb, has been trying to complete a separation since as early as 2020, first entertaining a spinoff and then a sale. Disagreements between shareholders ...

Feb 6 (Reuters) - Bausch + Lomb (BLCO.TO), opens new tab, will not be taken private at this time, the contact lens maker said on Thursday, sending its U.S.-listed shares down 7% to $16.50 in ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the commercial launch of the enVista Aspire ...

Niklas Beste was the driving force behind the attacking exploits of Bundesliga surprise package Heidenheim in 2023/24, and is now back in the Bundesliga with Freiburg. bundesliga.com looks into ...

Bausch + Lomb acquired Whitecap Biosciences to develop therapies for glaucoma and geographic atrophy, aiming to improve visual outcomes. Whitecap's WB007, an alpha-2 adrenergic agonist, showed IOP ...

Jersey City-based Character Biosciences, a company specializing in genetics-guided drug discovery and development, has announced a collaboration with Bausch + Lomb, a leading global eye health company ...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced an affiliate ...

Tune in here Atletico Madrid vs Bayer Leverkusen Live Score!